Cargando…
Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation
BACKGROUND: Cardiomyocyte apoptosis is critical for the development of coxsackievirus B3- (CVB3-) induced myocarditis, which is a common cardiac disease that may result in heart failure or even sudden death. Previous studies have associated CVB3-induced apoptosis with the downregulation of antiapopt...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431489/ https://www.ncbi.nlm.nih.gov/pubmed/30984342 http://dx.doi.org/10.1155/2019/9496419 |
_version_ | 1783405936496345088 |
---|---|
author | Li, Ping Yan, Yaoyao Shi, Youyang Cheng, Bo Zhan, Yi Wang, Qiaoyu Ye, Qiaofang Weng, Yawen Wu, Tingting Wu, Rongzhou |
author_facet | Li, Ping Yan, Yaoyao Shi, Youyang Cheng, Bo Zhan, Yi Wang, Qiaoyu Ye, Qiaofang Weng, Yawen Wu, Tingting Wu, Rongzhou |
author_sort | Li, Ping |
collection | PubMed |
description | BACKGROUND: Cardiomyocyte apoptosis is critical for the development of coxsackievirus B3- (CVB3-) induced myocarditis, which is a common cardiac disease that may result in heart failure or even sudden death. Previous studies have associated CVB3-induced apoptosis with the downregulation of antiapoptotic proteins. Here, attempts were made to examine whether nicotinic acetylcholine receptors (nAChRs), especially α3β4-nAChRs, were a novel therapeutic antiapoptotic target via the activation of survivin, a strong antiapoptotic protein, in viral myocarditis (VMC). METHODS AND RESULTS: In the present study, we demonstrated that nAChRs, α3β4-nAChR subunits in particular, were present and upregulated in CVB3-infected neonatal rat cardiomyocytes (NRC) and H9c2 cells by RT-qPCR. The function of α3β4-nAChRs was next examined using its specific blocker α-CTX AuIB in vitro. The results of the TUNEL assay and western blot experiments showed that the block of α3β4-nAChRs abrogated nicotine-mediated protection of NRC from CVB3-induced apoptosis, and this effect displayed a substantial correlation with the protein expressions of pAkt, survivin, and Cleaved Caspase-3. Hence, the involvement of the PI3K/Akt pathway was further verified by LY294002, a selective inhibitor of PI3K. As a result, nicotine-mediated induction of pAkt and survivin was abolished by LY294002; meanwhile, apoptotic NRC were increased accompanied by an increase of Cleaved Caspase-3 expression. Regarding CVB3-infected BALB/c mice, the α-CTX AuIB- and LY294002-treated groups had a lower survival rate, deteriorative ventricular systolic function, and more severe inflammation than the nicotine-treated group and the modulation of pAkt, survivin, and Cleaved Caspase-3 protein expressions was similar to that in CVB3-infected NRC. In addition, we found that a nicotinic agonist reduced CVB3 replication in a dose-dependent manner in vitro, which indicates that nAChR activation may serve as a possible protection mechanism of CVB3-induced myocarditis. CONCLUSIONS: Our study demonstrated that α3β4-nAChR subunits are essential in the nicotine-mediated antiapoptotic effect of protecting cardiomyocytes from CVB3-induced apoptosis in vivo and in vitro. This protection correlated with the PI3K/Akt pathway and the inducement of the antiapoptotic protein survivin. A combination of these mechanisms serves as a novel protective response to treat viral myocarditis. |
format | Online Article Text |
id | pubmed-6431489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-64314892019-04-14 Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation Li, Ping Yan, Yaoyao Shi, Youyang Cheng, Bo Zhan, Yi Wang, Qiaoyu Ye, Qiaofang Weng, Yawen Wu, Tingting Wu, Rongzhou Oxid Med Cell Longev Research Article BACKGROUND: Cardiomyocyte apoptosis is critical for the development of coxsackievirus B3- (CVB3-) induced myocarditis, which is a common cardiac disease that may result in heart failure or even sudden death. Previous studies have associated CVB3-induced apoptosis with the downregulation of antiapoptotic proteins. Here, attempts were made to examine whether nicotinic acetylcholine receptors (nAChRs), especially α3β4-nAChRs, were a novel therapeutic antiapoptotic target via the activation of survivin, a strong antiapoptotic protein, in viral myocarditis (VMC). METHODS AND RESULTS: In the present study, we demonstrated that nAChRs, α3β4-nAChR subunits in particular, were present and upregulated in CVB3-infected neonatal rat cardiomyocytes (NRC) and H9c2 cells by RT-qPCR. The function of α3β4-nAChRs was next examined using its specific blocker α-CTX AuIB in vitro. The results of the TUNEL assay and western blot experiments showed that the block of α3β4-nAChRs abrogated nicotine-mediated protection of NRC from CVB3-induced apoptosis, and this effect displayed a substantial correlation with the protein expressions of pAkt, survivin, and Cleaved Caspase-3. Hence, the involvement of the PI3K/Akt pathway was further verified by LY294002, a selective inhibitor of PI3K. As a result, nicotine-mediated induction of pAkt and survivin was abolished by LY294002; meanwhile, apoptotic NRC were increased accompanied by an increase of Cleaved Caspase-3 expression. Regarding CVB3-infected BALB/c mice, the α-CTX AuIB- and LY294002-treated groups had a lower survival rate, deteriorative ventricular systolic function, and more severe inflammation than the nicotine-treated group and the modulation of pAkt, survivin, and Cleaved Caspase-3 protein expressions was similar to that in CVB3-infected NRC. In addition, we found that a nicotinic agonist reduced CVB3 replication in a dose-dependent manner in vitro, which indicates that nAChR activation may serve as a possible protection mechanism of CVB3-induced myocarditis. CONCLUSIONS: Our study demonstrated that α3β4-nAChR subunits are essential in the nicotine-mediated antiapoptotic effect of protecting cardiomyocytes from CVB3-induced apoptosis in vivo and in vitro. This protection correlated with the PI3K/Akt pathway and the inducement of the antiapoptotic protein survivin. A combination of these mechanisms serves as a novel protective response to treat viral myocarditis. Hindawi 2019-03-07 /pmc/articles/PMC6431489/ /pubmed/30984342 http://dx.doi.org/10.1155/2019/9496419 Text en Copyright © 2019 Ping Li et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Li, Ping Yan, Yaoyao Shi, Youyang Cheng, Bo Zhan, Yi Wang, Qiaoyu Ye, Qiaofang Weng, Yawen Wu, Tingting Wu, Rongzhou Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation |
title | Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation |
title_full | Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation |
title_fullStr | Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation |
title_full_unstemmed | Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation |
title_short | Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation |
title_sort | nicotinic agonist inhibits cardiomyocyte apoptosis in cvb3-induced myocarditis via α3β4-nachr/pi3k/akt-dependent survivin upregulation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431489/ https://www.ncbi.nlm.nih.gov/pubmed/30984342 http://dx.doi.org/10.1155/2019/9496419 |
work_keys_str_mv | AT liping nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation AT yanyaoyao nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation AT shiyouyang nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation AT chengbo nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation AT zhanyi nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation AT wangqiaoyu nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation AT yeqiaofang nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation AT wengyawen nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation AT wutingting nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation AT wurongzhou nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation |